A local medical device startup has secured the FDA green light its pharmacist founder has been eyeing for more than a decade.

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial ...

A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within the cells.

From scaling laws and autonomous AI risks to the complexity of enterprise adoption, here’s what executives must know—and act on—over the next three years.

In today's increasingly competitive market, efficient response and exceptional cost-performance have become crucial for ...